Over-the-Counter Ibuprofen-Induced Pre-Pyloric Gastric Perforation in a 28-Month-Old Child: A Rare Pediatric Case

Wajeeh Uddin1, Mariam Aylan Alshamsi2,3, Vipul Gupta1

  • 1Pediatric Surgery and Urology, Al Jalila Children's Specialty Hospital, Dubai, ARE.

Cureus
|April 24, 2025
PubMed

Insights

Pediatric gastric perforation is a rare but serious condition. Concurrent use of over-the-counter ibuprofen and corticosteroids in children increases the risk of this life-threatening complication.

Area of Science:

  • Pediatric Surgery
  • Gastroenterology
  • Pharmacology

Background:

  • Gastric perforation is a rare cause of acute abdomen in children.
  • Concurrent use of non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids can increase gastric mucosal injury.

Observation:

  • A 28-month-old male with asthma developed gastric perforation after ibuprofen and oral steroid use.
  • Clinical presentation included acute epigastric pain, vomiting, and fever.
  • Radiographs showed pneumoperitoneum, confirmed as gastric perforation during laparoscopy.

Findings:

  • The patient underwent laparotomy and Graham patch repair for pre-pyloric gastric perforation.
  • Postoperative recovery was uneventful.
  • Further tests ruled out hypergastrinemia and Helicobacter pylori infection.

Implications:

  • Highlights the importance of medication history in pediatric acute abdomen cases.
  • Emphasizes the need for clinical suspicion of gastric perforation with NSAID and corticosteroid use.
  • Underscores the critical need for public health awareness regarding OTC NSAID risks in children.

Related Concept Videos

Esophageal Perforation-I: Introduction01:22

Esophageal Perforation-I: Introduction

Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
42
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
24
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
301
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
102
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
163
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
49